Shanghai Allist Pharmaceuticals Co., Ltd. (SHA:688578)
China flag China · Delayed Price · Currency is CNY
79.98
-1.58 (-1.94%)
Nov 17, 2026, 3:00 PM CST

SHA:688578 Financials Overview

Millions CNY. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
6,5905,1873,5582,018791530.09
Revenue Growth
38.51%45.80%76.29%155.14%49.22%94409.97%
Gross Profit
6,2835,0233,4141,940743.9500.14
Operating Income
3,1382,2971,475548.338.64-69.81
Net Income
2,9072,1891,430644.17130.5218.27
Earnings Per Share
6.464.863.181.430.290.04
EPS Growth
46.38%52.83%122.38%393.10%625.00%-

Revenue by Geography

Fiscal Year
FY 2025
Period EndingDec '25
China
5,152
Overseas
35
Total
5,187

Cash & Debt

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
3,7963,5463,6262,5122,0372,260
Total Debt
3.613.891.31.821.965.39
Net Cash (Debt)
3,7933,5423,6252,5102,0352,255
Net Cash Growth
15.81%-2.30%44.42%23.32%-9.73%-12.99%
Net Cash Per Share
8.437.868.065.574.524.94

Cash Flow & CapEx

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
3,0182,3231,566674.6591.6329.29
Capital Expenditures
-80.96-186-270.22-67.88-143.83-192.25
Free Cash Flow
2,9372,1371,296606.77-52.21-162.95
Free Cash Flow Growth
56.16%64.88%113.56%---

Margins

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
95.34%96.83%95.97%96.14%94.05%94.35%
Operating Margin
47.62%44.28%41.45%27.17%4.88%-13.17%
Pretax Margin
51.32%49.06%45.49%32.52%15.93%3.45%
Profit Margin
44.11%42.20%40.19%31.92%16.50%3.45%
FCF Margin
44.58%41.19%36.42%30.06%-6.60%-30.74%

Dividends

Fiscal Year
CurrentFY 2025FY 2024FY 2023
Period EndingNov '26 Dec '25 Dec '24 Dec '23
Dividend Per Share
1.2001.0000.6500.400
Dividend Per Share Growth
50.00%53.85%62.50%-
Dividend Yield
1.50%0.96%1.08%0.96%

Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingNov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PE Ratio
12.3821.4118.8529.1067.85743.66
Forward PE
12.5022.4517.6428.7074.26109.82
P/FCF Ratio
12.2521.9420.8030.90--
PS Ratio
5.469.047.589.2911.2025.64